HealthEquity

Forecast & Rating15 analysts currently cover HealthEquity, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $118.20, about 25.1% upside from the current price of $94.46. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 81.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study HealthEquity closely still see room for the stock to rise. Data as of Jul 22, 2026; for reference only and not investment advice.